Analyst Ratings February 3, 2026

Benchmark Cuts LiveRamp Price Target to $38 Citing Conservative Multiple; Buy Rating Intact

Analyst applies a 10x forward EV/Adj. EBITDA multiple as shares trade near 52-week lows ahead of fiscal Q3 results

By Sofia Navarro RAMP
Benchmark Cuts LiveRamp Price Target to $38 Citing Conservative Multiple; Buy Rating Intact
RAMP

Benchmark has reduced its 12-month price target for LiveRamp Holdings Inc. to $38 from $53 while keeping a Buy rating, citing a more cautious valuation approach based on a three-year average forward EV/Adjusted EBITDA multiple of 10x. The stock, trading around $23.12 and close to its 52-week low of $22.82, is viewed by the analyst as attractively priced relative to a Fair Value assessment. Benchmark's model shows shares at roughly 5.8x its conservative fiscal 2027 adjusted EBITDA forecast, with the research note noting a cash-rich balance sheet and active buybacks as potential supports to valuation. LiveRamp is due to report fiscal third-quarter results after market close on February 5, 2026.

Key Points

  • Benchmark reduced LiveRamp's price target to $38 from $53 but retained a Buy rating, applying a three-year average forward EV/Adjusted EBITDA multiple of 10x.
  • Shares trade near $23.12, close to a 52-week low of $22.82, and are viewed as undervalued relative to a Fair Value assessment; company balance sheet shows more cash than debt and active share buybacks.
  • Analyst forecasts conservative fiscal 2027-2029 CAGRs of 6.7% for revenue and 10.3% for adjusted EBITDA; LiveRamp will report fiscal Q3 results after market close on February 5, 2026.

Benchmark has lowered its price target for LiveRamp Holdings Inc. to $38.00 from $53.00 but left the stock's rating unchanged at Buy, according to a February 3 research note. The analyst recalculated the target using LiveRamp’s three-year average forward EV/Adjusted EBITDA multiple of 10x, a more conservative framework that aligns the firm with the broader analyst consensus.

Shares of LiveRamp (ticker: RAMP) were trading at $23.12 at the time of the note, hovering near a 52-week low of $22.82. Data referenced by the analyst indicate the equity may be undervalued relative to its Fair Value assessment, suggesting potential upside from current levels if company performance or market sentiment shifts.

Benchmark’s model places current trading at approximately 5.8x the firm’s conservative adjusted EBITDA estimate for fiscal 2027 - effectively the second year in its forward projection window. That multiple sits below the three-year average the analyst used to set the new target.

On the balance sheet front, the firm highlights that LiveRamp holds more cash than debt, and management has been repurchasing shares aggressively. Those features are noted as supportive elements for valuation resilience through rate cycles and could act as tailwinds if operating results improve.

The analyst projection set fiscal 2027-2029 compound annual growth rates at 6.7% for revenue and 10.3% for adjusted EBITDA. Benchmark characterizes those growth rates as conservative within its note.

LiveRamp is scheduled to release fiscal third-quarter earnings after the market close on February 5, 2026, an event that may recalibrate near-term investor expectations.


Recent company results and leadership update

In its Q2 2026 results, LiveRamp reported earnings per share of $0.42, missing the $0.51 consensus by 17.65%. Revenue for the quarter came in at $200.0 million, modestly above the $197.31 million estimate, a 1.36% positive surprise. Separately, LiveRamp announced that Chief Technology Officer Mohsin Hussain will depart at the end of fiscal 2026; the company filed the announcement in a press release with the Securities and Exchange Commission and provided no details about a successor or the transition process.

These mixed financial outcomes and the CTO departure are material near-term developments for investors to monitor ahead of the upcoming earnings release.


Context for investors

Benchmark’s narrower valuation lens - using a 10x forward EV/Adjusted EBITDA multiple - and its conservative growth assumptions anchor the lowered price target, while the maintained Buy rating reflects a view that the shares still have upside relative to the firm’s Fair Value assessment. Upcoming quarterly results and leadership transition details will be key inputs for revising outlooks and valuations.

Risks

  • Earnings risk from recent EPS miss - Q2 2026 EPS of $0.42 fell short of the $0.51 expectation, indicating potential volatility in near-term profitability - impacts technology and software earnings sentiment.
  • Leadership transition uncertainty - CTO Mohsin Hussain will leave at the end of fiscal 2026 and no successor or transition plan has been disclosed, creating execution risk for product and technology roadmaps.
  • Valuation sensitivity - Benchmark’s use of a conservative 10x EV/Adjusted EBITDA multiple and lower fiscal growth assumptions create downside if the business underperforms relative to even these cautious estimates; this affects investor valuation models in the software and advertising sectors.

More from Analyst Ratings

Freedom Capital Upholds Sell on ExxonMobil, Keeps $123 Target Despite Strong Ops Feb 3, 2026 Freedom Capital Keeps Buy on Flexsteel After Strong Q2; $54 Price Target Intact Feb 3, 2026 UBS Lifts ExxonMobil Price Target to $171 After Q4 Results Amid Operational Headwinds Feb 3, 2026 UBS Stays Bullish on Tenet as Conifer Ownership and Contract Terms Shift Feb 3, 2026 UBS Sticks With Neutral on Crocs as Market Sentiment Skews Bearish Feb 3, 2026